Publicação:
Prospective randomized study of peginterferon alpha-2a, ribavirin and amantadine vs peginterferon alpha-2a plus ribavirin, in hepatitis C patients now responders or relapsers to interferon-alpha and ribavirin

Página do item simplificado
dc.contributor.authorCheinquer, H.
dc.contributor.authorPessoa, M.
dc.contributor.authorAlmeida, P.
dc.contributor.authorSilva, G.
dc.contributor.authorPatelli, M.
dc.contributor.authorParana, R.
dc.contributor.authorParise, E.
dc.contributor.authorLacerda, M.
dc.contributor.authorPernambuco, J.
dc.contributor.authorPedrosa, S.
dc.contributor.authorTeixeira, R.
dc.contributor.authorTatsch, E.
dc.contributor.authorSette, H.
dc.contributor.institutionHosp Santa Casa
dc.contributor.institutionHosp Emilio Ribas
dc.contributor.institutionHosp Conceicao
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionPUCAMP
dc.contributor.institutionUniversidade Federal da Bahia (UFBA)
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionHosp Nossa Sra Das Gracas
dc.contributor.institutionUniversidade Federal de Pernambuco (UFPE)
dc.date.accessioned2014-05-20T15:23:11Z
dc.date.available2014-05-20T15:23:11Z
dc.date.issued2006-01-01
dc.description.affiliationHosp Santa Casa, Porto Alegre, RS, Brazil
dc.description.affiliationHosp Emilio Ribas, São Paulo, Brazil
dc.description.affiliationHosp Conceicao, Porto Alegre, RS, Brazil
dc.description.affiliationUniv Estadual Paulista Julio Mesquita Filho, Botucatu, SP, Brazil
dc.description.affiliationPUCAMP, Campinas, SP, Brazil
dc.description.affiliationUFBA, Salvador, BA, Brazil
dc.description.affiliationUNIFESP, São Paulo, Brazil
dc.description.affiliationHosp Nossa Sra Das Gracas, Curitiba, Parana, Brazil
dc.description.affiliationUFPE, Recife, PE, Brazil
dc.description.affiliationUnespUniv Estadual Paulista Julio Mesquita Filho, Botucatu, SP, Brazil
dc.format.extentS209-S209
dc.identifierhttp://dx.doi.org/10.1016/S0168-8278(06)80562-3
dc.identifier.citationJournal of Hepatology. Amsterdam: Elsevier B.V., v. 44, p. S209-S209, 2006.
dc.identifier.doi10.1016/S0168-8278(06)80562-3
dc.identifier.issn0168-8278
dc.identifier.urihttp://hdl.handle.net/11449/34019
dc.identifier.wosWOS:000237328100562
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofJournal of Hepatology
dc.relation.ispartofjcr14.911
dc.relation.ispartofsjr5,633
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.titleProspective randomized study of peginterferon alpha-2a, ribavirin and amantadine vs peginterferon alpha-2a plus ribavirin, in hepatitis C patients now responders or relapsers to interferon-alpha and ribavirinen
dc.typeResumo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:

Coleções

Artigos